This was also confirmed by the different phenotypes in the family of Patient 48, ranging from normal to Dravet syndrome in the carriers of the same SCN2A variant. This evidence concerns the gene SCN2A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.